New Medicine and the Fight Between USA and China
New Medicine and the Fight Between USA and China
新藥與美中之爭
Introduction
Companies now use computers and AI to make new medicine. The USA and China are fighting about these new medicines.
現在企業使用電腦與 AI 來研發新藥，而美國與中國正針對這些新藥展開競爭。
Main Body
Companies use AI to plan how to make drugs. This makes the work faster. A company called Moderna is also making new types of medicine.
公司使用 AI 來規劃如何研發藥物，這讓工作速度變得更快。一家名為 Moderna 的公司也在研發新類型的藥物。
China is making many new drugs. Now, China makes more new drugs than the USA. China sells these ideas for a lot of money.
中國正在研發許多新藥。現在，中國研發新藥的數量多於美國。中國以高價出售這些研發成果。
The USA is worried. They think China takes their ideas. The USA made a new law to stop China, but China is still growing.
美國感到擔憂。他們認為中國竊取了他們的創意。美國制定了新法律來阻止中國，但中國依然持續成長。
Conclusion
Technology is moving fast. The USA and China are still in a big competition.
科技進步神速，美國與中國仍處於激烈的競爭之中。
Vocabulary Learning
💡 The 'S' Rule for Actions
In this story, we see a pattern: when we talk about one company or one country, we add an -s to the action word.
Look at these examples:
- China makes drugs. (China = 1 country)
- The USA is worried. (USA = 1 country)
- Technology moves fast. (Technology = 1 thing)
Why this matters for A2: If you say "China make drugs," it sounds like a mistake. To sound like a pro, always add that -s for one person or thing.
Quick Guide: I make He/She/It makes I move It moves I use A company uses
Vocabulary Learning
Analysis of Current Trends in Global Biotechnology and US-China Tensions
全球生物技術現況趨勢與美中緊張關係分析
Introduction
The biotechnology industry is currently defined by the use of artificial intelligence in drug design, the development of mRNA therapies, and growing political tension regarding Chinese innovation.
目前的生物技術產業主要由人工智慧在藥物設計中的應用、mRNA療法的開發，以及針對中國創新的日益增加的政治緊張局勢所定義。
Main Body
The way drugs are discovered is changing as companies begin to use artificial intelligence. According to investor Clive Meanwell, the main benefit of AI is that it improves the overall design process of biotechnology rather than just creating single molecules. At the same time, Moderna is moving forward with its mRNA projects after a period of instability. In terms of finance, the sector remains active through Special Purpose Acquisition Companies (SPACs) and an increase in large pharmaceutical companies buying smaller biotech firms.
隨著公司開始使用人工智慧，藥物研發的方式正在改變。根據投資者 Clive Meanwell 的說法，AI 的主要優勢在於改善了生物技術整體的設計流程，而非僅僅創造單一分子。同時，Moderna 在經歷了一段不穩定時期後，正推進其 mRNA 項目。在財務方面，該產業透過特殊目的收購公司（SPACs）以及大型製藥公司收購小型生物技術公司而保持活躍。
Regarding global politics, the rapid growth of the Chinese biotech sector has caused significant concern in the United States. Data from Pharmcube shows that China now accounts for 34% of the approximately 14,088 new drugs in global clinical development, which is higher than the US share of 27%. Furthermore, China provides 40% of all new drugs entering the clinical stage every year. This growth is clear from the fact that licensing agreements increased nearly tenfold between 2021 and 2025, reaching a value of $137.7 billion. Consequently, US policymakers have expressed worries about intellectual property theft and the power of state-owned companies. This has led to laws like the Biosecure Act, although some officials argue that these measures have not stopped China's progress.
關於全球政治，中國生物技術產業的快速增長引起了美國的嚴重關注。Pharmcube 的數據顯示，在全球約 14,088 個處於臨床開發階段的新藥中，中國目前佔 34%，高於美國的 27%。此外，每年進入臨床階段的所有新藥中，中國提供了 40%。從 2021 年至 2025 年間，授權協議增加近十倍，價值達到 1,377 億美元，足以體現此增長趨勢。因此，美國政策制定者對知識產權盜用以及國有企業的影響力表示擔憂。這導致了如《生物安全法案》（Biosecure Act）等法律的出台，儘管部分官員認為這些措施並未能阻止中國的進展。
Conclusion
The global biotech industry continues to be shaped by fast technological growth and an increasing strategic competition between the US and China.
全球生物技術產業將繼續受到快速技術成長以及美中之間日益激烈的戰略競爭影響。
Vocabulary Learning
⚡ The 'B2 Pivot': Moving from Simple to Complex Connections
An A2 student says: "China is growing. The US is worried."
A B2 student says: "The rapid growth of the Chinese biotech sector has caused significant concern in the United States."
What changed? We stopped using two small sentences and started using a Cause-and-Effect Bridge.
🛠️ The Tool: Nominalization
In the text, we see a powerful shift. Instead of saying "China grew quickly" (Verb), the author uses "The rapid growth of the Chinese biotech sector" (Noun phrase).
When you turn an action (grow) into a thing (growth), you can describe it with adjectives (rapid) and make it the subject of your sentence. This is the secret to sounding professional and academic.
Compare these shifts:
| A2 Style (Simple Action) | B2 Style (The 'Thing') |
|---|---|
| AI helps design drugs. | The use of artificial intelligence in drug design... |
| The sector is unstable. | ...after a period of instability. |
| Licensing agreements increased. | ...the increase in licensing agreements. |
🚀 Level Up Your Logic
To reach B2, you must stop using 'and' or 'but' for everything. Look at how the text links a fact to a result:
"...licensing agreements increased nearly tenfold... Consequently, US policymakers have expressed worries..."
The Power Word: Consequently
- Meaning: "As a result of this."
- Usage: Use it at the start of a sentence to show that the second fact happened because of the first fact. It is the 'adult' version of 'so'.
Quick Formula for you:
[Fact A] + . + Consequently, + [Result B].
Vocabulary Learning
Analysis of Contemporary Developments in Global Biotechnology and Sino-American Sectoral Tensions.
全球生物技術當前發展分析及中美產業緊張局勢
Introduction
The biotechnology sector is currently characterized by the integration of artificial intelligence in drug design, the evolution of mRNA therapeutic strategies, and escalating geopolitical friction regarding Chinese innovation.
生物技術產業目前的特徵在於將人工智慧整合至藥物設計、mRNA 治療策略的演進，以及針對中國創新而日益劇烈的地緣政治摩擦。
Main Body
The operational paradigm of drug discovery is undergoing a transition toward the utilization of artificial intelligence. According to investor Clive Meanwell, the primary utility of AI resides in the optimization of macro-level biotechnological design processes rather than the synthesis of individual molecules. Concurrently, Moderna is advancing its mRNA initiatives following a period of developmental instability. In the financial domain, the sector continues to see activity via Special Purpose Acquisition Companies (SPACs) and an increase in pharmaceutical acquisitions of smaller biotech entities.
藥物研發的運作模式正轉向利用人工智慧。根據投資者 Clive Meanwell 的看法，AI 的主要效用在於優化宏觀層級的生物技術設計流程，而非合成單一分子。與此同時，Moderna 在經歷一段發展不穩定的時期後，正推進其 mRNA 計畫。在金融領域，該產業持續透過特殊目的收購公司 (SPACs) 保持活躍，且藥廠收購小型生物技術實體的現象有所增加。
Regarding the geopolitical landscape, the proliferation of the Chinese biotechnology sector has generated significant scrutiny within the United States. Data from Pharmcube indicates that China currently accounts for 34% of the approximately 14,088 new drugs in global clinical development, surpassing the United States' 27% share. Furthermore, China contributes 40% of new drugs entering the clinical stage annually. This expansion is evidenced by a nearly tenfold increase in out-licensing agreements between 2021 and 2025, reaching a valuation of $137.7 billion. Consequently, U.S. policymakers have expressed concerns regarding the integrity of intellectual property and the influence of state-operated enterprises, leading to legislative efforts such as the Biosecure Act, although some officials contend these measures have not sufficiently curtailed China's ascent.
關於地緣政治局勢，中國生物技術產業的擴張引起了美國的高度關注。根據 Pharmcube 的數據，在全球約 14,088 種處於臨床開發階段的新藥中，中國目前佔 34%，超過美國的 27%。此外，每年進入臨床階段的新藥中，中國貢獻了 40%。這種擴張體現在 2021 年至 2025 年間，外部授權協議數量增加近十倍，估值達到 1,377 億美元。因此，美國政策制定者對知識產權的完整性及國有企業的影響表示擔憂，導致了如《生物安全法案》(Biosecure Act) 等立法努力，儘管部分官員認為這些措施尚未能充分遏制中國的崛起。
Conclusion
The global biotech landscape remains defined by rapid technological acceleration and a deepening strategic rivalry between the U.S. and China.
全球生物技術格局依然由快速的技術加速，以及中美之間深層次的戰略競爭所定義。
Vocabulary Learning
The Architecture of 'Nominal Density' and the C2 Precision Shift
To move from B2 to C2, a student must transition from describing actions to conceptualizing states. The provided text is a masterclass in Nominalization—the process of turning verbs and adjectives into nouns to create a high-density, academic register.
◈ The Linguistic Pivot
Observe the phrase: "The operational paradigm of drug discovery is undergoing a transition toward the utilization of artificial intelligence."
At a B2 level, a writer might say: "Companies are changing how they discover drugs by using AI."
Why the C2 version is superior:
- Abstraction over Action: Instead of "changing" (verb), we have "undergoing a transition" (noun phrase). This shifts the focus from the actor to the process.
- Precision of Scope: "Utilization" is more precise than "using," implying a strategic or systematic application.
- Conceptual Anchoring: "Operational paradigm" creates a theoretical framework for the sentence, allowing the writer to discuss the nature of the change rather than just the change itself.
◈ Deconstructing the 'Academic Weight'
| B2 Construction (Action-Oriented) | C2 Construction (Concept-Oriented) | Linguistic Mechanism |
|---|---|---|
| China is expanding quickly | The proliferation of the Chinese biotechnology sector | Nominalization (Expand Proliferation) |
| This shows that... | This expansion is evidenced by... | Passive Agency (Replacing 'This shows' with a state of evidence) |
| They are worried about IP | Concerns regarding the integrity of intellectual property | Abstract Noun Pairing (Concern + Integrity) |
◈ Scholarly Application: The "Sino-American" Modifier
Note the use of "Sino-American Sectoral Tensions." At C2, we employ attributive adjectives (Sino-, Sectoral) to compress vast amounts of information into a single noun phrase. This eliminates the need for clunky relative clauses (e.g., "tensions that are between China and America and relate to specific sectors").
The C2 Mantra: Minimize pronouns, maximize nouns, and anchor your verbs in states of being or transition rather than simple action.